Stock listing
OTC:MDNC Medinotec Inc. Stock
Follow Medinotec Inc. into a list and get an email when it puts out news.
Share price · OTC:MDNC
$5.00 USD 0.00 (0.0%)
Close on Oct 23, 2026
- Day range
- $5.00 – $5.00 USDOct 23, 2026
- Market cap
- —Left out: too few shares trade to back it
- 52-week range
- $5.00 – $5.00 USDLowest and highest trades, Oct 24, 2025 – Oct 23, 2026
- Traded on an average day
- $0 USDMedian day 0 shares · 66 days with no trades · last 3 months, Jul 23, 2026 – Oct 23, 2026

Daily closes
Last 3 months, Jul 23, 2026 – Oct 23, 2026 · OTC:MDNC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.00 | $5.00 | 0 |
- Ticker
- OTC:MDNC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- OTC
- Currency
- USD
Latest news
Life Science Investor Forum: Presentations Now Available for Online Viewing
Jun 23, 2023
Issued by another party
Medinotec Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 4 in all · newest Jun 23, 2023 · oldest 2023
Valuation
Statements: 4 quarters to Aug 31, 2026 · price Oct 23, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- 49.9%
- Operating margin
- 6.6%
- Net margin
- 5.9%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.00
Team and board
| Officer | Role |
|---|---|
| Gregory Vizirgianakis | Group Chief Executive Officer |
| Pieter van Niekerk | Group Chief Financial Officer |
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | 9.73M | 9.11M | 5.02M | 999.6K |
| Cost of revenue | 4.60M | 4.30M | -2.58M | -417.8K |
| Gross profit | 5.13M | 4.82M | 2.44M | 581.8K |
| Research and development | 149.9K | 91.1K | -22.4K | -64.9K |
| Operating income | 1.09M | 3.19M | 600.6K | -238.6K |
| Depreciation and amortization | 80.9K | 73.8K | 88.2K | 53.6K |
| EBITDA | 1.18M | 3.27M | 688.8K | -185.0K |
| Interest expense | 87.6K | 176.4K | -277.2K | -226.8K |
| Income before tax | 1.07M | 3.02M | -253.8K | -391.5K |
| Income tax | -274.7K | -864.7K | -150.9K | 38.7K |
| Net income | 794.5K | 2.16M | -404.7K | -352.7K |
| Earnings per share, basic | 0.07 | 0.18 | -0.03 | -0.03 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Cash and equivalents | 2.76M | 2.77M | 2.81M | 2.83M |
| Receivables | 2.35M | 2.61M | 589.8K | 21.1K |
| Current assets | 6.42M | 6.42M | 4.38M | 3.37M |
| Property, plant and equipment | 331.3K | 348.5K | 320.1K | 406.9K |
| Total assets | 6.81M | 6.81M | 4.80M | 4.49M |
| Current liabilities | 1.10M | 1.51M | 827.5K | 71.3K |
| Total liabilities | 1.10M | 2.54M | 2.64M | 1.93M |
| Shareholders' equity | 5.71M | 4.27M | 2.17M | 2.56M |
| Shares outstanding | 11.8M | 11.7M | 11.7M | 11.7K |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Cash from operations | 906.8K | 877.8K | 14.2K | -490.5K |
| Capital spending | -1.36K | -89.0K | -2.25K | -55.3K |
| Free cash flow | 905.4K | 788.8K | 12.0K | -545.8K |
| Cash from investing | -1.36K | -89.0K | 10.1K | -529.7K |
| Cash from financing | -983.0K | -894.5K | -8.09K | 3.58M |
| Change in cash | -12.7K | -39.2K | -18.5K | 2.70M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Oct 8, 2026 | Quarterly report | SEC |
| 10-Q · Quarterly report | Jul 9, 2026 | Quarterly report | SEC |
| 10-K · Annual report | May 28, 2026 | Annual report | SEC |
| 8-K · Current report | Jan 20, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Jan 9, 2026 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Jan 2, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | Oct 8, 2025 | Quarterly report | SEC |
| 10-Q · Quarterly report | Jul 16, 2025 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Jul 16, 2025 | Explanation request | SEC |
| 3 · Initial statement of ownership | Jun 17, 2025 | Insider trade | SEC |
All 54 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13D · Big-stake notice | Jun 12, 2025 | Big-stake notice | SEC |
| SCHEDULE 13D · Big-stake notice | Jun 12, 2025 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Jun 12, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 12, 2025 | Insider trade | SEC |
| 10-K · Annual report | May 29, 2025 | Annual report | SEC |
| 3 · Initial statement of ownership | May 22, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 22, 2025 | Insider trade | SEC |
| 8-A12G · Registration of a class of shares | Apr 16, 2025 | Other filings | SEC |
| 8-K · Current report | Jan 27, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Jan 14, 2025 | Quarterly report | SEC |
| 10-Q · Quarterly report | Oct 15, 2024 | Quarterly report | SEC |
| 10-Q · Quarterly report | Jul 12, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jul 10, 2024 | Current report | SEC |
| 10-K · Annual report | Jul 3, 2024 | Annual report | SEC |
| NT 10-K · Late filing notice | May 29, 2024 | Explanation request | SEC |
| 8-K · Current report | Mar 19, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Mar 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Feb 26, 2024 | Current report | SEC |
| NT 10-Q · Late filing notice | Jan 12, 2024 | Explanation request | SEC |
| 10-Q · Quarterly report | Oct 13, 2023 | Quarterly report | SEC |
| 8-K · Current report | Oct 12, 2023 | Management or board change | SEC |
| 10-Q · Quarterly report | Jul 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jun 21, 2023 | Current report | SEC |
| 10-K · Annual report | May 30, 2023 | Annual report | SEC |
| 8-K · Current report | May 17, 2023 | Current report | SEC |
| 8-K · Current report | Mar 31, 2023 | Current report | SEC |
| 8-K · Current report | Mar 22, 2023 | Current report | SEC |
| 8-K · Current report | Mar 13, 2023 | Current report | SEC |
| 8-K · Current report | Feb 8, 2023 | Results | SEC |
| 8-K · Current report | Jan 19, 2023 | Results | SEC |
| 10-Q · Quarterly report | Jan 17, 2023 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Dec 2, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 29, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Nov 18, 2022 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Nov 14, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Nov 2, 2022 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Oct 13, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Sep 29, 2022 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Sep 15, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Aug 30, 2022 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Aug 18, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Aug 4, 2022 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jun 28, 2022 | Other filings | SEC |
| S-1 · Registration statement | Jun 2, 2022 | Offer document | SEC |
Cap table
Built by 6ix from Medinotec Inc.’s releases · as of Oct 8, 2026
- Common shares
- 11,755,548
- Fully diluted
- 11,755,548
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 11,755,548 | Oct 8, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 8, 2026 | 11,755,548 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Stavros G. Vizirgianakis Other companies: Apyx Medical Corporation (Chairman of the Board · Since at least May 7, 2024); Xtant Medical Holdings, Inc. (Director · Since at least Aug 25, 2022); Bioventus Inc. (Director · Oct 29, 2021 – Jun 16, 2022 · Past); Misonix Inc (President and CEO, Director · May 7, 2013 – Oct 29, 2021 · Past) | Director · Apr 16, 2025 – Apr 16, 2025 · Past |
| Gregory Vizirgianakis | Group Chief Executive Officer · Since at least Apr 16, 2025 |
| Pieter van Niekerk | Group Chief Financial Officer · Since at least Apr 16, 2025 |
Log in to ask 6ix AI your own questions about Medinotec Inc.